We are live on
!
Find out more
PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.08B
1-Year Est. Return
29.51%
This Fund
S&P 500
This Quarter
Est. Return
+9.49%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4B
AUM Growth
-$87.6M
(-2.1%)
Cap. Flow
-$382M
Cap. Flow
% of AUM
-9.54%
Top 10 Holdings %
Top 10 Hldgs %
10.92%
Holding
332
New
81
Increased
58
Reduced
167
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$26.7M |
| 2 |
SKX
Skechers
SKX
|
+$26.5M |
| 3 |
CIR
CIRCOR International, Inc
CIR
|
+$21.9M |
| 4 |
AGCO
AGCO
|
+$18.4M |
| 5 |
GrafTech
EAF
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIVB
SVB Financial Group
SIVB
|
+$45.4M |
| 2 |
MSCC
Microsemi Corp
MSCC
|
+$43.6M |
| 3 |
Shopify
SHOP
|
+$33.1M |
| 4 |
Atlassian
TEAM
|
+$31.9M |
| 5 |
REVG
REV Group
REVG
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Healthcare | 19.25% |
| 3 | Industrials | 16.69% |
| 4 | Financials | 12.38% |
| 5 | Consumer Discretionary | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VCRA
126
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $14.2M | 0.35% |
474,093
+17,954
| +4% | +$477K |
|
|
CLDR
127
DELISTED
Cloudera, Inc.
CLDR
| $13.9M | 0.35% |
1,016,921
-121,300
| -11% | -$1.85M |
|
128
Ionis Pharmaceuticals
IONS
$9.4B
| $13.6M | 0.34% |
+326,765
| New | +$14.5M |
|
129
Cerus
CERS
$474M
| $13.4M | 0.33% |
2,005,565
-120,588
| -6% | -$740K |
|
130
Tyler Technologies
TYL
$12.8B
| $13.2M | 0.33% |
59,229
+192
| +0.3% | +$43.2K |
|
|
ICPT
131
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.7M | 0.32% |
151,434
+36,189
| +31% | +$2.65M |
|
|
KTWO
132
DELISTED
K2M Group Holdings, Inc
KTWO
| $12.7M | 0.32% |
562,613
-33,985
| -6% | -$716K |
|
133
MarketAxess Holdings
MKTX
$5.72B
| $12.6M | 0.32% |
63,762
+203
| +0.3% | +$42.1K |
|
134
Verisk Analytics
VRSK
$25B
| $12.5M | 0.31% |
116,533
+394
| +0.3% | +$41.9K |
|
135
Booking.com
BKNG
$161B
| $12.4M | 0.31% |
+153,275
| New | +$12.9M |
|
|
HMHC
136
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $11.4M | 0.29% |
1,494,181
+330,689
| +28% | +$2.35M |
|
|
GDEN
137
DELISTED
Golden Entertainment
GDEN
| $11.4M | 0.29% |
423,344
-25,796
| -6% | -$720K |
|
138
Onto Innovation
ONTO
$15.3B
| $11M | 0.27% |
309,771
-235,962
| -43% | -$8.08M |
|
139
ICF International
ICFI
$1.72B
| $10.9M | 0.27% |
153,541
+15,621
| +11% | +$1.06M |
|
140
Kemper
KMPR
$1.68B
| $10.8M | 0.27% |
142,937
-32,702
| -19% | -$2.3M |
|
141
Gartner
IT
$11.7B
| $10.8M | 0.27% |
81,200
+264
| +0.3% | +$33.8K |
|
|
LKFT
142
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $9.93M | 0.25% |
107,675
+5,539
| +5% | +$537K |
|
143
Precigen
PGEN
$2.59B
| $9.91M | 0.25% |
711,266
+96,393
| +16% | +$1.63M |
|
|
MGLN
144
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.57M | 0.24% |
99,774
+8,198
| +9% | +$786K |
|
145
Visteon
VC
$2.78B
| $9.46M | 0.24% |
73,230
-16,630
| -19% | -$2.08M |
|
146
Century Communities
CCS
$2.03B
| $9.43M | 0.24% |
298,799
-68,264
| -19% | -$2.1M |
|
|
SBNY
147
DELISTED
Signature Bank
SBNY
| $9.25M | 0.23% |
72,311
-3,208
| -4% | -$421K |
|
148
Okta
OKTA
$25.8B
| $8.78M | 0.22% |
174,391
-66,456
| -28% | -$3.16M |
|
149
Pacira BioSciences
PCRX
$997M
| $8.67M | 0.22% |
270,573
-55,483
| -17% | -$1.92M |
|
|
SGMO
150
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $8.62M | 0.22% |
607,063
+206,657
| +52% | +$3.43M |
|
Similar funds
CAM
MRCP
ECP
HCM
TCG
CLG
SAG
EP
Peregrine Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Peregrine Capital Management held 332 positions worth $4B, down 2.1% from $4.09B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Peregrine Capital Management withdrew a net $382M in Q2 2018, closing 25 positions and reducing 167 holdings. Its most notable exit was Microsemi Corp, an estimated $43.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Peregrine Capital Management opened a new position in Syneos Health, Inc. Class A Common Stock worth $30.2M.
- Peregrine Capital Management's largest Q2 2018 buy was Syneos Health, Inc. Class A Common Stock: 644,491 shares worth $30.2M.
- Peregrine Capital Management added most to QTS REALTY TRUST, INC. in Q2 2018, an estimated $8.36M increase.
- Peregrine Capital Management's biggest Q2 2018 reduction was SVB Financial Group, cutting an estimated $45.4M.
- Peregrine Capital Management fully exited Microsemi Corp in Q2 2018, selling an estimated $43.6M.
- Peregrine Capital Management's ten largest holdings make up 11% of its $4B portfolio in Q2 2018.
- Peregrine Capital Management opened 81 new positions and closed 25 in Q2 2018.
- Peregrine Capital Management's portfolio value fell 2.1% quarter-over-quarter to $4B.
Based on Peregrine Capital Management's 13F filing for Q2 2018, filed 12 Jul 2018.